Haemonetics (HAE) stock a good investment now? Daily analysis covers institutional ownership, earnings surprises, growth catalysts and future growth opportunities for investors. Haemonetics Corporation (HAE) closed at $66.38, down 0.69% in the most recent trading session. The stock is currently positioned above its key support level of $63.06 and below resistance at $69.70, suggesting the shares are in a consolidative phase after recent declines.
Haemonetics (HAE) Slips Modestly as Stock Tests Support Near $63 - Backspread Trade
HAE - Stock Analysis
3789 Comments
1236 Likes
2
{用户名称}
{用户等级}
5 hours ago
{协议答案}
👍 150
Reply
3
{用户名称}
{用户等级}
1 day ago
{协议答案}
👍 143
Reply
4
{用户名称}
{用户等级}
1 day ago
{协议答案}
👍 78
Reply
5
{用户名称}
{用户等级}
2 days ago
{协议答案}
👍 270
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.